Natriumklorid Braun (Sodium Chloride)

Sodium Chloride, the active ingredient in Natriumklorid Braun, is an electrolyte solution presented as an injection solution for intravenous use. It is employed to restore extracellular fluid volume and maintain electrolyte balance in patients requiring fluid replacement, such as those with hypovolemia, dehydration, burns, or postoperative fluid loss.

GNH USA supplies Natriumklorid Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support global distribution.

Natriumklorid Braun is used as an intravenous electrolyte solution to manage conditions involving fluid loss and electrolyte imbalance. - Fluid replacement: restores intravascular volume and improves tissue perfusion in patients with acute fluid loss. - Electrolyte replenishment: supplies sodium and chloride ions to correct deficits and maintain plasma osmolarity. - Hypovolemia: increases circulating blood volume to stabilize blood pressure in hypovolemic shock. - Dehydration: rehydrates patients by expanding extracellular fluid compartments.

Intravenous administration of sodium chloride may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Injection site pain: mild discomfort or burning at the infusion site. - Phlebitis: inflammation of the vein used for administration. - Hypernatremia: elevated serum sodium if excessive volumes are infused. - Fluid overload: signs of edema or increased blood pressure. - Electrolyte imbalance: transient shifts in chloride or bicarbonate levels. - Allergic reaction: rash or urticaria in sensitive individuals.

Serious or Rare Side Effects: - Severe hypernatremia: neurological symptoms such as confusion or seizures. - Pulmonary edema: respiratory distress due to fluid accumulation in lungs. - Anaphylaxis: rapid onset of airway swelling, hypotension, and shock. - Cardiac arrhythmia: abnormal heart rhythms linked to electrolyte disturbances. - Severe hypertension: abrupt rise in blood pressure requiring intervention.

Before using Natriumklorid Braun, clinicians should evaluate patient status and monitor key parameters to minimize risks. - Assess volume status: determine dehydration or overload before initiating infusion. - Monitor serum electrolytes: check sodium and chloride levels regularly during therapy. - Adjust infusion rate in cardiac or renal disease: reduce speed to avoid fluid accumulation. - Use caution in neonates and infants: lower volumes are required and tolerance is limited. - Avoid in existing hypernatremia: do not administer if serum sodium is already elevated. - Store at ambient temperature: keep in original container, protect from light, and do not freeze.

Sodium chloride solution can interact with other intravenous agents or medications that affect fluid and electrolyte balance.

Major Interactions (Avoid): - Hypertonic saline solutions: concurrent use may cause severe hypernatremia. - Potassium chloride admixtures: risk of precipitation and catheter occlusion. - Bicarbonate solutions: incompatibility leading to precipitation of salts.

Moderate Interactions (Monitor Closely): - Loop diuretics: increase renal sodium loss, requiring electrolyte monitoring. - ACE inhibitors or ARBs: may potentiate changes in serum potassium when combined with potassium supplements. - Corticosteroids: can promote fluid retention, necessitating careful volume assessment.